83 related articles for article (PubMed ID: 22816666)
21. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
Mukherjee S; Ahmed A; Nandi D
J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
[TBL] [Abstract][Full Text] [Related]
22. Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.
Heidt S; Roelen DL; Eijsink C; Eikmans M; van Kooten C; Claas FH; Mulder A
Clin Exp Immunol; 2010 Feb; 159(2):199-207. PubMed ID: 19922499
[TBL] [Abstract][Full Text] [Related]
23. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
Hermann P; Van-Kooten C; Gaillard C; Banchereau J; Blanchard D
Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
[TBL] [Abstract][Full Text] [Related]
24. Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cells.
Plumas J; Chaperot L; Jacob MC; Molens JP; Giroux C; Sotto JJ; Bensa JC
Eur J Immunol; 1995 Dec; 25(12):3332-41. PubMed ID: 8566020
[TBL] [Abstract][Full Text] [Related]
25. Sotrastaurin, a protein kinase C inhibitor for the prevention of transplant rejection and treatment of psoriasis.
Manicassamy S
Curr Opin Investig Drugs; 2009 Nov; 10(11):1225-35. PubMed ID: 19876790
[TBL] [Abstract][Full Text] [Related]
26. Effect of mycophenolic acid and bortezomib on purified human B cells: an in vitro study of long-term functionally stable MICA-sensitized renal recipients.
Li Zw; Wen Xf; Wang Y; Luo M; Qiu Jx
Exp Clin Transplant; 2013 Dec; 11(6):482-8. PubMed ID: 23745955
[TBL] [Abstract][Full Text] [Related]
27. Conversion to everolimus in maintenance patients--current clinical strategies.
Pohanka E
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii24-9. PubMed ID: 16815853
[TBL] [Abstract][Full Text] [Related]
28. The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation.
Evenou JP; Wagner J; Zenke G; Brinkmann V; Wagner K; Kovarik J; Welzenbach KA; Weitz-Schmidt G; Guntermann C; Towbin H; Cottens S; Kaminski S; Letschka T; Lutz-Nicoladoni C; Gruber T; Hermann-Kleiter N; Thuille N; Baier G
J Pharmacol Exp Ther; 2009 Sep; 330(3):792-801. PubMed ID: 19491325
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
[TBL] [Abstract][Full Text] [Related]
30. Bortezomib affects the function of human B cells: possible implications for desensitization protocols.
Heidt S; Roelen DL; Vergunst M; Doxiadis II; Claas FH; Mulder A
Clin Transpl; 2009; ():387-92. PubMed ID: 20524303
[TBL] [Abstract][Full Text] [Related]
31. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.
Petersen J
Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810
[TBL] [Abstract][Full Text] [Related]
32. Sotrastaurin and everolimus pharmacokinetics after single-dose coadministration.
Kovarik JM; Bartlett M; Rordorf C; Antunes MC; Winter S; Marbach P; van Marle S
Int J Clin Pharmacol Ther; 2010 Feb; 48(2):103-8. PubMed ID: 20137762
[TBL] [Abstract][Full Text] [Related]
33. The protein kinase C inhibitor sotrastaurin allows regulatory T cell function.
de Weerd A; Kho M; Kraaijeveld R; Zuiderwijk J; Weimar W; Baan C
Clin Exp Immunol; 2014 Feb; 175(2):296-304. PubMed ID: 24131367
[TBL] [Abstract][Full Text] [Related]
34. The effects of immunosuppressive agents on in vitro production of human immunoglobulins.
Stevens C; Lempert N; Freed BM
Transplantation; 1991 Jun; 51(6):1240-4. PubMed ID: 1710843
[TBL] [Abstract][Full Text] [Related]
35. Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.
Friman S; Arns W; Nashan B; Vincenti F; Banas B; Budde K; Cibrik D; Chan L; Klempnauer J; Mulgaonkar S; Nicholson M; Wahlberg J; Wissing KM; Abrams K; Witte S; Woodle ES
Am J Transplant; 2011 Jul; 11(7):1444-55. PubMed ID: 21564523
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of expression of cyclin A in human B cells by an immunosuppressant mizoribine.
Hirohata S; Yanagida T
J Immunol; 1995 Dec; 155(11):5175-83. PubMed ID: 7594527
[TBL] [Abstract][Full Text] [Related]
37. Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium.
Lemster B; Woo J; Strednak J; Wang SC; Todo S; Starzl TE; Thomson AW
Transplant Proc; 1992 Dec; 24(6):2845-6. PubMed ID: 1281576
[No Abstract] [Full Text] [Related]
38. In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443.
Allison AC; Almquist SJ; Muller CD; Eugui EM
Transplant Proc; 1991 Apr; 23(2 Suppl 2):10-4. PubMed ID: 2063415
[No Abstract] [Full Text] [Related]
39. In human cell cultures, everolimus is inferior to tacrolimus in inhibiting cellular alloimmunity, but equally effective as regards humoral alloimmunity.
Eleftheriadis T; Pissas G; Sounidaki M; Antoniadi G; Antoniadis N; Liakopoulos V; Stefanidis I
Int Urol Nephrol; 2017 Sep; 49(9):1691-1697. PubMed ID: 28508247
[TBL] [Abstract][Full Text] [Related]
40. Brequinar sodium inhibits interleukin-6-induced differentiation of a human B-cell line into IgM-secreting plasma cells.
Tamura K; Woo J; Bakri MT; Thomson AW
Immunology; 1993 Aug; 79(4):587-93. PubMed ID: 8406583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
